Krystal Biotech, Inc. financial data

Symbol
KRYS on Nasdaq
Location
Pittsburgh, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 03 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 911% % -15%
Quick Ratio 35% % 73%
Debt-to-equity 10% % 19%
Return On Equity 19% % 205%
Return On Assets 18% % 201%
Operating Margin 42% % 272%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28,997,519 shares 0.82%
Common Stock, Shares, Outstanding 28,984,000 shares 0.79%
Entity Public Float $4,600,000,000 USD 64%
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 28,953,000 shares 0.82%
Weighted Average Number of Shares Outstanding, Diluted 29,833,000 shares -0.23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $373,165,000 USD 55%
Research and Development Expense $56,771,000 USD 10%
Operating Income (Loss) $158,199,000 USD 475%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $186,949,000 USD 61%
Income Tax Expense (Benefit) $11,961,000 USD -1313%
Net Income (Loss) Attributable to Parent $198,910,000 USD 280%
Earnings Per Share, Basic 6 USD/shares 237%
Earnings Per Share, Diluted 6 USD/shares 221%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $392,604,000 USD 5%
Cash, Cash Equivalents, and Short-term Investments $731,100,000 USD 24%
Accounts Receivable, after Allowance for Credit Loss, Current $129,633,000 USD 33%
Inventory, Net $37,632,000 USD 103%
Assets, Current $925,650,000 USD 30%
Deferred Income Tax Assets, Net $24,680,000 USD
Property, Plant and Equipment, Net $148,871,000 USD -4.9%
Operating Lease, Right-of-Use Asset $7,447,000 USD 15%
Other Assets, Noncurrent $333,000 USD 64%
Assets $1,240,094,000 USD 26%
Accounts Payable, Current $2,097,000 USD -62%
Liabilities, Current $91,268,000 USD 1.9%
Operating Lease, Liability, Noncurrent $7,813,000 USD 26%
Other Liabilities, Noncurrent $3,137,000 USD 312%
Liabilities $102,218,000 USD 6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,100,000 USD -27%
Retained Earnings (Accumulated Deficit) $27,237,000 USD 88%
Stockholders' Equity Attributable to Parent $1,137,876,000 USD 28%
Liabilities and Equity $1,240,094,000 USD 26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $30,969,000 USD 95%
Net Cash Provided by (Used in) Financing Activities $12,466,000 USD -218%
Net Cash Provided by (Used in) Investing Activities $54,769,000 USD -111%
Common Stock, Shares Authorized 80,000,000 shares 0%
Common Stock, Shares, Issued 28,984,000 shares 0.79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $36,095,000 USD -5424%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $392,604,000 USD 5%
Deferred Tax Assets, Valuation Allowance $68,094,000 USD -12%
Deferred Tax Assets, Gross $83,138,000 USD -9.2%
Operating Lease, Liability $9,511,000 USD 27%
Depreciation $5,550,000 USD -8.1%
Payments to Acquire Property, Plant, and Equipment $6,204,000 USD 392%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $198,498,000 USD 266%
Lessee, Operating Lease, Liability, to be Paid $17,419,000 USD 16%
Property, Plant and Equipment, Gross $178,043,000 USD 0.94%
Operating Lease, Liability, Current $1,698,000 USD 31%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,919,000 USD 50%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,865,000 USD 46%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7,908,000 USD 5.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,954,000 USD 50%
Deferred Tax Assets, Operating Loss Carryforwards $14,539,000 USD -64%
Unrecognized Tax Benefits $4,152,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,990,000 USD 50%
Additional Paid in Capital $1,164,013,000 USD 4.8%
Deferred Tax Assets, Net of Valuation Allowance $15,044,000 USD 3%